GlassScriptPhysician profile
Celines Morales-Ribeiro
NPI 1164672895
$6,981.64
in general payments reported to CMS, 2019-2025
19 companies · $239 in 2025
The $239 reported for 2025 was less than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,437 · 2020: $69.42 · 2021: $172 · 2022: $2,411 · 2023: $1,196 · 2024: $457 · 2025: $239.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $800 · Food and Beverage: $735 · Travel and Lodging: $206 · Education: $151.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $800.00 |
| Food and Beverage | $735.26 |
| Travel and Lodging | $206.00 |
| Education | $151.32 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $4,962.72 | 2019-2023 | Da Vinci Surgical System |
| Ethicon INC. | $814.09 | 2023-2025 | Vistaseal |
| Ethicon US, LLC | $265.54 | 2022-2025 | Stratafix, Surgicel Nu-Knit, Echelon; Endopath |
| W. L. Gore & Associates, INC. | $254.03 | 2021-2023 | Gore Synecor Biomaterial |
| Daiichi Sankyo INC. | $121.95 | 2019-2021 | |
| Davol INC. | $119.75 | 2021-2025 | Channel Drain, Phasix Mesh |
| Novo Nordisk INC | $65.10 | 2020-2022 | |
| Lilly USA, LLC | $56.12 | 2024-2025 | Zepbound |
| Teleflex LLC | $54.39 | 2023-2025 | Titan Sgs Standard Gastric Stapler, Titan Sgs Bailout Chuck |
| Kerecis Limited | $53.97 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Medtronic, INC. | $48.53 | 2022-2023 | Signia |
| Vertex Pharmaceuticals Incorporated | $35.75 | 2024-2025 | |
| Endo Pharmaceuticals INC. | $28.85 | 2019-2021 | |
| Cumberland Pharmaceuticals, INC. | $25.26 | 2019-2023 | Caldolor |
| Currax Pharmaceuticals LLC | $17.20 | 2025 | Contrave |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Specialty Surgical Instrumentation | $16.61 | 2021 | |
| Vivus LLC | $15.00 | 2022 | |
| Heron Therapeutics, INC. | $15.00 | 2022 | |
| Cook Medical LLC | $11.78 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Celines Morales-Ribeiro listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.